WuXi Biologics and Medigene link on T cell engagers for cancer

Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.

Aug 11, 2024 - 04:00

WuXi Biologics and Medigene link on T cell engagers for cancer

Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.

Read the original article

Tags:

Previous Article

Gilead Sciences reports net income rise in Q2 2024

How the GLP-1 receptor agonist market could hit $168bn by 2033

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

AION Labs and BioMed X launch sixth challenge for AI-dr...

May 30, 2023

Inline, real-time PAT tool is a game-changer for pharma granulation sector

Inline, real-time PAT tool is a game-changer for pharma...

Jun 4, 2024

SIM-325 by TCR Cure Biopharma Technology for Head And N...

Dec 4, 2023